Khow KS, Kee MW, Shibu PN, Yu SC, Chehade MJ, Visvanathan R. Relationship between perioperative anaemia and outcomes in older people with hip fractures: A systematic review and meta-analysis protocol. World J Meta-Anal 2019; 7(6): 290-296
Corresponding Author of This Article
Kareeann SF Khow, FRACP, MBChB, Research Fellow, Senior Lecturer, Staff Physician, Aged and Extended Care Services, the Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, SA 5011, Australia. email@example.com
Checklist of Responsibilities for the Scientific Editor of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Relationship between perioperative anaemia and outcomes in older people with hip fractures: A systematic review and meta-analysis protocol
Kareeann SF Khow, Michelle WK Kee, Pazhvoor N Shibu, Solomon CY Yu, Mellick J Chehade, Renuka Visvanathan
Kareeann SF Khow, Michelle WK Kee, Pazhvoor N Shibu, Solomon CY Yu, Renuka Visvanathan, Aged and Extended Care Services, the Queen Elizabeth Hospital, Woodville South, SA 5011, Australia
Kareeann SF Khow, Pazhvoor N Shibu, Solomon CY Yu, Renuka Visvanathan, Centre of Research Excellence, Frailty Trans-disciplinary Research to Achieve Healthy Ageing, University of Adelaide, Adelaide, SA 5005, Australia
Mellick J Chehade, Discipline of Orthopaedics and Trauma, Faculty of Medical and Health Sciences, University of Adelaide, Adelaide, SA 5005, Australia
Author contributions: Khow KSF, Kee MWK, Shibu PN, Yu SCY, Chehade MJ and Visvanathan R contributed equally to the work; Khow KSF conceptualized and designed the review together with Kee MWK; Khow KSF drafted the initial paper; all authors reviewed and approved the final manuscript as submitted.
Conflict-of-interest statement: Dr Shibu has received educational grants and honoraria from Novartis Pty Australia and Amgen Pty Ltd. Associate Professor Chehade has received institutional research grant from Stryker and Amgen Pty Ltd. Professor Visvanathan has participated in international initiatives funded by educational grants from Nestle and has presented at symposiums funded by Nestle. She is on the Malnutrition in the Elderly Board with Nestle Australia. Dr Khow, Dr Kee and Associate Professor Yu do not have any conflict of interests.
PRISMA 2009 Checklist statement: The manuscript is designed as per PRISMA 2009 guideline, and checklist is provided as supplementary file.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Kareeann SF Khow, FRACP, MBChB, Research Fellow, Senior Lecturer, Staff Physician, Aged and Extended Care Services, the Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, SA 5011, Australia. firstname.lastname@example.org
Telephone: +61-8-83132144 Fax: +61-8-83132155
Received: April 28, 2019 Peer-review started: April 28, 2019 First decision: May 9, 2019 Revised: June 1, 2019 Accepted: June 17, 2019 Article in press: June 17, 2019 Published online: June 30, 2019
Hip fractures are common with increasing age and is associated with decline in mobility. Both the fracture and the surgery can lead to blood loss, resulting in anaemia. However, it is uncertain at which time point haemoglobin is most strongly associated with different clinical outcomes after hip fracture. Our hypothesis is perioperative anaemia (admission, postoperative and discharge) during hip fracture surgery is associated with poor clinical outcomes.
To determine the effects of perioperative anaemia during hip fracture surgery on mortality, functional status and other clinical outcomes.
Electronic databases will be searched to identify studies evaluating perioperative anaemia and outcomes of hip fracture surgery. Reference lists of included studies will also be searched to identify additional published studies. Eligibility criteria are as follows: Population: People who underwent hip fracture surgery; Exposure: Perioperative anaemia; Comparison: No anaemia before or after hip fracture surgery; Outcome: Mortality, hospital length of stay, postoperative complications, hospital readmission, change of discharge destination, quality of life and functional status. Risk of bias assessment will be assessed using the Cochrane Collaboration’s tool for randomized controlled trials and the modified version of the Epidemiological Appraisal Instrument for observational studies. Data will be pooled for meta-analysis if deemed appropriate.
This review seeks to clarify outcomes associated with perioperative anaemia at various time-points around hip fracture surgery. These findings will potentially inform evidence-based clinical practice on interventions in those with anaemia.
Core tip: Hip fracture is a growing public health problem because of population aging. Recovery from hip fracture can be slow and complicated by morbidities and decline in functional abilities. Perioperative anaemia is common with hip fractures. However, it is uncertain at which time point haemoglobin level is most strongly associated with different clinical outcomes after hip fracture surgery. Better understanding of the relationship between perioperative haemoglobin and mortality, length of hospital stay, functional status, postoperative complications, hospital readmission and admission to residential care after discharge, is required.
Citation: Khow KS, Kee MW, Shibu PN, Yu SC, Chehade MJ, Visvanathan R. Relationship between perioperative anaemia and outcomes in older people with hip fractures: A systematic review and meta-analysis protocol. World J Meta-Anal 2019; 7(6): 290-296
Mobility is vital to older people, especially for maintaining functional independence and good quality of life. Older people have identified that living in their own home as long as possible is a priority for them. However, sustaining a hip fracture is a serious life-changing event for many older people, which disrupts their ability to walk.
Hip fractures in the older population are associated with adverse outcomes which may include prolonged hospitalisation, decline in functional status, long-term institu-tionalisation and excessive mortality[1-3]. For example, less than 50% of patients regain their prior level of mobility at one year after hip fracture, and nearly 20% become immobile. The loss of independence after hip fractures result in older people needing long-term residential care. In a meta-analysis of seventy-five studies involv-ing more than 64000 subjects from multiple countries, the overall mortality at one year was 24.5% and this increased to 34.5% at 2 years. Therefore, the healthcare burden of hip fractures is significant and strategies are needed to mitigate these adverse outcomes.
One potential way to improve outcomes after hip fractures is to better manage anaemia in patients with hip fractures. Hip fractures are associated with significant blood loss, either from the fracture itself or from the surgery to repair it. In the gene-ral population, anaemia is present in 10% of women and 11% of men over the age of 65 years. This prevalence of anaemia is higher in older people who had hip fractures. It is present in approximately 50% at the time of hospital admission, increasing to more than 90% following hip fracture surgery. Anaemia, independent of other health conditions, places older people at risk of adverse health outcomes. The increa-sed risk of mortality among those with anaemia is well documented[9,10]. However, there is conflicting data about whether anaemia is an independent risk factor for poor postoperative outcome or a marker of severity of comorbid diseases in patients with hip fractures[9,11].
Preoperative anaemia is recognised as a risk factor for mortality, longer length of stay and poorer functional status after hip fracture surgery. It is also recognised as one of the most important risk factor for blood transfusions[12,13]. In a systematic review published in 2015, preoperative anaemia was associated with a 64% increase in risk of mortality after hip fractures. One of the limitations of this systematic review is that several studies published after 2015 were not included.
In a few studies, the effects of postoperative haemoglobin on clinical outcomes have shown mixed results[15,16]. In addition, little is known about the effects of anaemia prior to hospital discharge on outcomes. To date, only a small number of studies have examined the association between anaemia on discharge with outcomes[8,17,18]. Therefore, a more robust review is required to evaluate the relationship between pe-rioperative anaemia and clinical outcomes in hip fracture surgery.
The primary aim of this systematic review is to determine the relationship between perioperative (preoperative, postoperative and discharge) anaemia and mortality after hip fracture surgery. Secondary aims are to evaluate the relationship between perioperative anaemia and other clinical outcomes such as hospital length of stay, postoperative complications, hospital readmission, rate of permanent transfer to residential care after discharge, and functional status in terms of mobility or disability.
MATERIALS AND METHODS
This systematic review and meta-analysis will be performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) statement.
Anaemia refers to a reduced number of circulating red blood cells and is usually based on haemoglobin measurements. Anaemia can occur at various time point of the fracture, either preoperatively (prior to surgery) or postoperatively (up to 7 dafter surgery). There is also interest in haemoglobin just before discharge following the index surgery. These measurements are collectively referred to as perioperative hae-moglobin.
We will search for relevant articles in the English language using MEDLINE/ PubMed, CINAHL, SCOPUS, EMBASE databases and Cochrane Library from inception until August 2018. The search strategy is provided in Table 1. We will perform a manual search of additional references of articles.
("anaemia" [All Fields] OR "anaemia" [MeSH Terms] OR "haemoglobin" [All Fields]) OR ("haemoglobin" [MeSH Terms] AND ("hip fractures" [MeSH Terms] OR ("hip" [All Fields] AND "fractures" [All Fields])
“hip fracture” AND (anaemia or haemoglobin)
“hip fracture” and (anaemia or haemoglobin)
Hip fracture AND (anaemia or haemoglobin)
Population: The population of interest is people with hip fractures undergoing surgery. Examples of surgery for hip fractures include sliding hip screw, intramedu-llary nail and arthroplasty.
Exposure: Studies evaluating the effects of perioperative anaemia which are defined as (1) at the time of admission or before surgery; (2) after surgery (within 7 d); and (3) prior to hospital discharge (as defined by the authors) will be included. Anaemia may be defined according to the World Health Organization criteria as haemoglobin concentration less than 120 g/L for women and less than 130 g/L for men. For the purpose of this review, moderate and severe anaemia were defined as haemoglobin of 80-100 g/L and less than 80 g/L, respectively, for both sexes.
Comparator/control: Participants who had hip fracture surgery without anaemia, at different time points.
Outcomes: This review will consider studies that include any of the following outcomes (1) mortality up to 12 mo post-surgery; (2) hospital length of stay; (3) postoperative complications; (4) hospital readmission; (5) rate of permanent transfer to residential care after discharge; (6) quality of life; (7) mobility or disability.
Study design: All peer-reviewed full-text studies or doctoral dissertations are eligible for initial review. Observational studies designed as longitudinal cohorts, case-control or cross-sectional studies and experimental studies designed as rando-mized controlled or non-randomized trials will be eligible for inclusion in this review.
Exclusion: This study will exclude case series, case reports and studies published in a language other than English. Studies reporting outcomes of cohorts with (1) acetabulum and fractures of the femoral shaft distal to the subtrochanteric region, (b) high-energy traumatic fracture; (2) pathological fracture and (3) non-surgical management of hip fracture will also be excluded.
Study selection process
Initially, two reviewers (KSK, MWK) will screen the titles and abstracts of all search records independently. After screening, full texts of all potentially eligible studies will be retrieved and examined according to the abovementioned eligibility criteria. Disagreements at both screening levels (title/abstract and full text) will be adjudicat-ed by a third reviewer (SY). A PRISMA-P flow chart will outline the study selection process and reasons for exclusion.
Data will be extracted by two independent reviewers (KSK, MWK) using a standard data abstraction form (Supplementary material). After determination of the study eligibility, information will be extracted from each study regarding study identifica-tion (first author, year of publication, number and location where recruitment took place), study design characteristics (sample size, follow-up duration, inclusion and exclusion criteria, quality assessments), patient population (age, gender, medical comorbidities) and haemoglobin levels (before, after surgery or prior to discharge). Data on the following outcomes will be recorded: mortality up to 12 mo, hospital length of stay, postoperative complications, hospital readmission up to 12 mo, rate of permanent transfer to residential care after discharge, quality of life, mobility or disability.
The quality assessment for all studies will be assessed independently by two reviewers (KSK, MWK). The Cochrane Collaboration’s tool will be used for assessing risk of bias among RCT studies. This tool addresses six domains of bias: (1) Sequence generation; (2) Allocation concealment; (3) Blinding of personnel and participants; (4) Completeness of data; (5) Selective reporting; and (6) Other source of bias not covered in the other domains. Based on empirical and theoretical considera-tions, RCTs with inadequate random sequence generation, allocation concealment, incomplete outcome data, selective reporting, or with other sources of bias will be considered as high risk of bias. When sufficient information was not provided on these three domains of bias to allow a definite judgement, we will consider the risk of bias as unclear. When a study is potentially free of these biases, we will consider the risk as low.
The quality of observational studies will be assessed using the Epidemiological Appraisal Instrument (EAI), a validated and reliable tool. This instrument addresses five domains of bias risk: Reporting, subject selection, measurement quality, data analysis, and generalisation of results. Each of the 43 questions in the EAI was scored as yes (= 2), partial (= 1), no or unable to determine (= 0) with the highest possible score being 86. Each total score will be stratified by quartiles. Quartile 1 (Q1) will be 70-86 (the highest quality), quartile 2 (Q2) will be 46-69, quartile 3 (Q3) will be 24-45 and quartile 4 (Q4) will be 0-23 (the lowest quality). Any disagreement regarding the quality of a study will be resolved by a third reviewer (SY).
Detailed description of all included studies will be tabulated. Study identification (first author, year of publication, number and location where recruitment occurred), study design and characteristics (observational or experimental, sample size, duration of follow-up), patient population (age, gender), haemoglobin at different time points and clinical outcomes (mortality at different time points, hospital length of stay, hospital readmission at different time points, postoperative complications, rate of admission to residential care after discharge, quality of life, mobility or ability to perform activities of daily living) will be qualitatively described.
We will use RevMan 5.3 to conduct the meta-analyses. Meta-analyses of pooled data will not be performed for secondary outcomes or when the number of studies were small or highly heterogenous. The summary effect measures may include hazard ratios (HR), relative risk (RR) or odds ratios (OR). When data are available to be pooled together, we will use a random-effects model to estimate of effect size. Where possible, we will aggregate each included study’s outcome data as HR, RR, or OR with the associated 95%CI as these are assumed to measure the same underlying effect. When the effect size estimate was not reported in the paper, the RR or OR and associated 95%CI will be calculated using the raw data available. In the first instance, the unadjusted effect sizes for each outcome (permitting age and sex adjustment) will be pooled together. In the second instance, the unadjusted and most adjusted effect sizes for each outcome will be pooled together.
Heterogeneity and publication bias
Heterogeneity among included studies will be evaluated using the I2 statistic, which will describe the proportion of variability in effect size estimates that is due to the difference between studies rather than by chance. According to the Cochrane Handbook for Systematic Reviews, I2 of 0% to 60% can be considered as not impor-tant to moderate, while I2 >60% indicates substantial heterogeneity.
Funnel plots will be used to assess for any publication bias (eyeball test). Egger’s test will be used to identify any funnel plot asymmetry arising from publication bias if present.
This systematic review aims to add to the existing literature by aggregating data on specific outcomes after hip fracture surgery in relation to perioperative anaemia. Our review is broader in scope and considers many more clinical outcomes compared with previous systematic reviews that have predominantly focused on postoperative mortality. Understanding the relationship between perioperative anaemia in hip fracture surgery and clinical outcomes is important from a clinical perspective because clinicians find it challenging to know when to transfuse with RBC. Therefore, this review will inform the evidence-based recommendations for this area of clinical practice.
It is common when undertaking such reviews and meta-analysis that gaps in methodology will be identified and as part of quality improvement, strategies to address these design gaps will be identified. Additionally, areas where knowledge gaps remain may be identified to guide future research directions for the benefit of the clinical care of people with hip fractures.
It can be hypothesized that this review will encounter several limitations. This review may not be able to generalize the findings because studies may potentially define anaemia by different haemoglobin cut-offs leading to variation in interpre-tation. Therefore, the proposed review may be limited by the pooling together of perioperative anaemia studies with varying levels of validity and heterogeneity. Another limitation concerns the length of stay and functional status endpoints, and it is possible that different studies may have utilized different methods to determine these outcomes, each with varying levels of validity.
In conclusion, given that the links between anaemia and clinical outcomes at different time-points before or after hip fracture surgery are complex and the lack of a comprehensive systematic review in this area, the proposed review will help to provide a summary of the available evidence. These findings will assist the develop-ment of future clinical practice and policy in this field.
Perioperative anaemia in hip fracture is a common problem that can influence clinical outcomes. However, it is uncertain which outcomes will be affected and if anaemia before or after surgery will have different effects.
A better understanding of how perioperative anaemia influences clinical outcomes after hip fracture surgery will help to develop more timely interventions.
To determine the effects of perioperative anaemia during hip fracture surgery on mortality, hospital length of stay, postoperative complications, hospital readmission, change of discharge destination, quality of life and functional status.
Electronic databases will be searched for studies evaluating perioperative anaemia and outcomes of hip fracture surgery. Data on study characteristics, patient demographics, timing of anaemia and clinical outcomes will be extracted. Comparison will be made between participants with anaemia and those without. Data will be pooled for meta-analysis for the primary outcome.
This systematic review seeks to clarify the outcomes associated with perioperative anaemia at various time-points among patients who had hip fracture surgery. An evaluation of the outcomes associated with perioperative anaemia in hip fracture surgery will potentially inform evidence-based clinical practice on the effectiveness and timing of interventions in those with reduced haemoglobin.
In presence of small studies evaluating perioperative anaemia among older people having hip fracture surgery, a systematic review and meta-analysis will provide important directions for future research and clinical practice in this field. This protocol will provide an important methodological foundation for the systematic review.
Dr Khow is a recipient of the National Health and Medical Research Council Postgra-duate Scholarship (2017-2018).
Manuscript source: Unsolicited Manuscript
Specialty type: Medicine, Research and Experimental
Country of origin: Australia
Peer-review report classification
Grade A (Excellent): 0
Grade B (Very good): B
Grade C (Good): 0
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Petretta M S-Editor: Cui LJ L-Editor: A E-Editor: Wang J
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review.Osteoporos Int. 2009;20:1633-1650.
Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, Chrischilles EA, Pavlik CE, Wallace RB, Ohsfeldt RL, Jones MP, Rosenthal GE, Wolinsky FD. The aftermath of hip fracture: discharge placement, functional status change, and mortality.Am J Epidemiol. 2009;170:1290-1299.
Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States.JAMA. 2009;302:1573-1579.
Vochteloo AJ, Moerman S, Tuinebreijer WE, Maier AB, de Vries MR, Bloem RM, Nelissen RG, Pilot P. More than half of hip fracture patients do not regain mobility in the first postoperative year.Geriatr Gerontol Int. 2013;13:334-341.
Hu F, Jiang C, Shen J, Tang P, Wang Y. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis.Injury. 2012;43:676-685.
Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture.Injury. 2011;42:133-135.
Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.Blood. 2004;104:2263-2268.
Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J, Koval KJ, Siu AL. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture.J Orthop Trauma. 2004;18:369-374.
Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization.J Gerontol A Biol Sci Med Sci. 2006;61:474-479.
Dong X, Mendes de Leon C, Artz A, Tang Y, Shah R, Evans D. A population-based study of hemoglobin, race, and mortality in elderly persons.J Gerontol A Biol Sci Med Sci. 2008;63:873-878.
Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly.Am J Med. 2006;119:327-334.
Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery.Br J Surg. 2015;102:1314-1324.
Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study.Anesthesiology. 2009;110:574-581.
Potter LJ, Doleman B, Moppett IK. A systematic review of pre-operative anaemia and blood transfusion in patients with fractured hips.Anaesthesia. 2015;70:483-500.
Lawrence VA, Silverstein JH, Cornell JE, Pederson T, Noveck H, Carson JL. Higher Hb level is associated with better early functional recovery after hip fracture repair.Transfusion. 2003;43:1717-1722.
Willems JM, de Craen AJ, Nelissen RG, van Luijt PA, Westendorp RG, Blauw GJ. Haemoglobin predicts length of hospital stay after hip fracture surgery in older patients.Maturitas. 2012;72:225-228.
Su H, Aharonoff GB, Zuckerman JD, Egol KA, Koval KJ. The relation between discharge hemoglobin and outcome after hip fracture.Am J Orthop (Belle Mead NJ). 2004;33:576-580.
Adunsky A, Arad M, Blumstein T, Weitzman A, Mizrahi EH. Discharge hemoglobin and functional outcome of elderly hip fractured patients undergoing rehabilitation.Eur J Phys Rehabil Med. 2008;44:417-422.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.Syst Rev. 2015;4:1.
Nutritional Anaemias. Report of a WHO scientific group. World Health Organization Technical Report Series.